182 related articles for article (PubMed ID: 28056062)
1. Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks.
Suresh M; Korolowicz KE; Balarezo M; Iyer RP; Padmanabhan S; Cleary D; Gimi R; Sheri A; Yon C; Kallakury BV; Tucker RD; Afdhal N; Menne S
PLoS One; 2017; 12(1):e0169631. PubMed ID: 28056062
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B.
Korolowicz KE; Iyer RP; Czerwinski S; Suresh M; Yang J; Padmanabhan S; Sheri A; Pandey RK; Skell J; Marquis JK; Kallakury BV; Tucker RD; Menne S
PLoS One; 2016; 11(8):e0161313. PubMed ID: 27552102
[TBL] [Abstract][Full Text] [Related]
3. Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Leng X; Kallakury BV; Tucker RD; Menne S
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918831
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection.
Meng Z; Zhang X; Pei R; Zhang E; Kemper T; Vollmer J; Davis HL; Glebe D; Gerlich W; Roggendorf M; Lu M
Antiviral Res; 2016 Jan; 125():14-24. PubMed ID: 26585244
[TBL] [Abstract][Full Text] [Related]
10. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.
Colonno RJ; Genovesi EV; Medina I; Lamb L; Durham SK; Huang ML; Corey L; Littlejohn M; Locarnini S; Tennant BC; Rose B; Clark JM
J Infect Dis; 2001 Nov; 184(10):1236-45. PubMed ID: 11679911
[TBL] [Abstract][Full Text] [Related]
11. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
[TBL] [Abstract][Full Text] [Related]
12. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
[TBL] [Abstract][Full Text] [Related]
13. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
Michalak TI; Zhang H; Churchill ND; Larsson T; Johansson NG; Oberg B
Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
[TBL] [Abstract][Full Text] [Related]
14. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.
Mason WS; Xu C; Low HC; Saputelli J; Aldrich CE; Scougall C; Grosse A; Colonno R; Litwin S; Jilbert AR
J Virol; 2009 Feb; 83(4):1778-89. PubMed ID: 19073743
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
16. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
Front Immunol; 2021; 12():745802. PubMed ID: 34671360
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
[TBL] [Abstract][Full Text] [Related]
18. Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks.
Suresh M; Czerwinski S; Murreddu MG; Kallakury BV; Ramesh A; Gudima SO; Menne S
PLoS Pathog; 2019 Dec; 15(12):e1008248. PubMed ID: 31869393
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.
Crettaz J; Otano I; Ochoa-Callejero L; Benito A; Paneda A; Aurrekoetxea I; Berraondo P; RodrÃguez-Madoz JR; Astudillo A; Kreppel F; Kochanek S; Ruiz J; Menne S; Prieto J; Gonzalez-Aseguinolaza G
J Virol; 2009 Mar; 83(6):2663-74. PubMed ID: 19116251
[TBL] [Abstract][Full Text] [Related]
20. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
